TP53 and hepatocellular carcinoma: In HCC, miR-21 inhibited the expression of the p53 activator HBP1, diminishing the p53 tumor suppression activity, and augmenting the expression of SREBP1c which promoted lipid accumulation and hepatic tumorigenesis [57].